Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 1867-1872, September 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anigstein, L.
Right arrow Articles by O'Steen, W. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anigstein, L.
Right arrow Articles by O'Steen, W. K.

Induced Alteration of Resistance to Transplantable Mammary Adenocarcinoma in Mice Neonatally Inoculated with Rat Thymus Antiserum1

Ludwik Anigstein, Dorothy M. Anigstein, Edward G. Rennels and W. Keith O'Steen

Department of Preventive Medicine and Public Health and Department of Anatomy, University of Texas Medical Branch, Galveston, Texas

Two strains of Swiss mice have been utilized in this study. One strain of mice, designated as Strain R, has been relatively resistant to transplantable mouse adenocarcinoma (10% acceptance). The 2nd strain of mice (Strain S) from which the tumor was originally isolated, was used for maintenance and for comparative growth (80–100% acceptance). A series of young adult R mice, some neonatally inoculated with rat thymus antiserum (produced in rabbits) or normal rabbit serum along with a similar series of uninoculated control groups of R and S mice, were given implantations of adenocarcinoma tissue fragments. After 22 days of growth, 19 out of 28 adenocarcinoma implants were accepted (possibly delayed rejection) in the Group R mice treated with thymus antiserum. In the littermates treated with normal rabbit serum, only 1 tumor out of 24 implants was accepted and no tumors grew in the uninoculated R mice.

1 This investigation was supported in whole by USPHS Research Grant 3R10-CA-08013-02-S1 from the National Cancer Institute.

Received 2/10/66.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.